The original group of Swiss mice that served as progenitors of this stock consisted of two male and seven female albino mice derived from a non-inbred stock in the laboratory of Dr. de Coulon, Centre Anticancereux Romand, Lausanne, Switzerland. These animals were imported into the United States by Dr. Clara Lynch of the Rockefeller Institute in 1926. The Hauschka Ha/ICR stock was initiated in 1948 at the Institute for Cancer Research (ICR) in Philadelphia from “Swiss” mice of Rockefeller origin. To Dr. Edward Mirand of Roswell Park Memorial Institute where they were designated as HaM/ICR. To Charles River in 1959.Note: We also offer the CD1-Elite Mouse with a VAF/Elite® health profile (bred in US).
General multipurpose model, safety and efficacy testing, aging, pseudopregnancy, surgical model
Informational Resources: CD-1® Mouse
CD-1 Mouse Health Reports
*This pricing is subject to our General Terms & Conditions of Sale.
Health Reports for Animal Colonies in Germany
Download Price List »
Health Reports for Animal Colonies in UK
Health Report for Animal Colonies in France
Health Reports for Animal Colonies in Italy
Health Reports for Animal Colonies in Japan
For additional information, including pricing details, please visit the CD-1® mouse page on the Charles River Japan website.
We perform various rodent surgeries, from simple procedures to highly complex catheterizations/cannulations.
Our animals can be fed a specialized diet or aged in order to meet your specific research requirements.
We can supply your in-house microinjection programs with blastocysts and superovulated or pseudopregnant mice.